pallko/pallko embryonic macrophages display defects in apoptotic cells clearance and have significantly lower phagocytic index compared to wild-type.
The survival rate of pallko/pallko adults upon infection with both Gram-positive and Gram-negative bacteria as well as their survival of septic injuries are comparable to that of controls. The uptake of bacteria during injections or the subsequent phagosomal degradation of bacteria are also unchanged in pallko/pallko adults compared to controls.
pallko is a non-enhancer of abnormal immune response | adult stage phenotype of imdR156
pallko has embryonic/larval plasmatocyte | embryonic stage phenotype, suppressible by RpS6WG1288/RpS6WG1288
pallko has embryonic/larval plasmatocyte | embryonic stage phenotype, suppressible by Rac2UAS.cUa/Scer\GAL4crq.Unk
pallko has embryonic/larval plasmatocyte | embryonic stage phenotype, non-suppressible by RpS6WG1288/RpS6[+]
The defects in phagocytic apoptotic cells clearance displayed by homozygous pallko mutant embryos can be rescued by combination with RpS6WG1288 in homozygous, but not heterozygous state.
The defects in phagocytic apoptotic cells clearance displayed by homozygous pallko mutant embryos can be suppressed by expression of Rac2Scer\UAS.cUa under the control of Scer\GAL4crq.Unk in the mutant background.
The low survival rate upon septic injury characteristic for imdR156 mutant adults remains unchanged in imdR156;pallko double mutants.